IQVIA Holdings Inc BRDR I1QV34
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- R$81.60
- Day Range
- R$79.70–80.00
- 52-Week Range
- R$49.30–86.31
- Bid/Ask
- R$0.00 / R$0.00
- Shares Outstanding
- 2.63B
- Market Cap
- R$209.90B
- Volume/Avg
- 200 / 390
Key Statistics
- Price/Earnings (Normalized)
- 19.31
- Price/Sales
- 2.41
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- 2.87%
Company Profile
Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services with extensive healthcare data and analytics. Its research and development solutions segment provides outsourced clinical development services spanning drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process. Its commercial solutions segment helps companies optimize product commercialization through analytics, technology, and outsourced sales and medical services. Together, Iqvia supports customers across the life science industry, and it serves biopharmaceutical firms, providers, payers, and policymakers.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Stock Style Box
- Mid Core
- Total Number of Employees
- 94,000
- Website
- https://www.iqvia.com
Competitors
Valuation
|
Metric
|
I1QV34
|
FTRE
|
ICLR
|
|---|---|---|---|
Price/Earnings (Normalized) | 19.31 | 155.89 | 18.88 |
Price/Book Value | 6.55 | 3.78 | 1.35 |
Price/Sales | 2.41 | 0.72 | 1.53 |
Price/Cash Flow | 15.65 | 37.10 | 13.27 |
Price/Earnings
I1QV34
FTRE
ICLR
Financial Strength
|
Metric
|
I1QV34
|
FTRE
|
ICLR
|
|---|---|---|---|
Quick Ratio | 0.62 | 0.85 | 0.92 |
Current Ratio | 0.71 | 0.96 | 0.95 |
Interest Coverage | 2.99 | 0.08 | 1.53 |
Quick Ratio
I1QV34
FTRE
ICLR
Profitability
|
Metric
|
I1QV34
|
FTRE
|
ICLR
|
|---|---|---|---|
Return on Assets (Normalized) | 7.22% | 2.15% | 3.91% |
Return on Equity (Normalized) | 34.41% | 10.56% | 6.87% |
Return on Invested Capital (Normalized) | 12.37% | 7.32% | 6.21% |
Return on Assets
I1QV34
FTRE
ICLR
Diagnostics & Research Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Thermo Fisher Scientific Inc
TMO
| LOCK|$flSm&< | LOCK|f^ | $243B | |||
| Danaher Corp
DHR
| LOCK|l^<?^G@ | LOCK|^# | $155B | |||
| Agilent Technologies Inc
A
| LOCK|$n@C$X>J | LOCK|l%Z | $48B | |||
| IQVIA Holdings Inc
IQV
| LOCK|CR>f^q | LOCK|PZY? | $43B | |||
| Waters Corp
WAT
| LOCK|!g<&VJ | LOCK|^^ | $43B | |||
| Illumina Inc
ILMN
| LOCK|mz??cW | LOCK|R!w> | $42B | |||
| IDEXX Laboratories Inc
IDXX
| LOCK|>p#C#l? | LOCK|>P@ | $41B | |||
| Mettler-Toledo International Inc
MTD
| LOCK|BzB>KYB | LOCK|$<s@ | $31B | |||
| Quest Diagnostics Inc
DGX
| LOCK|#@?!#S | LOCK|FdW& | $25B | |||
| Labcorp Holdings Inc
LH
| LOCK|fhX><>M | LOCK|wN&kj | $25B |
United States